Cargando…

Observation of an E2 (Ubc9)-homodimer by crystallography

Post-translational modifications by the small ubiquitin-like modifiers (SUMO), in particular the formation of poly-SUMO-2 and -3 chains, regulates essential cellular functions and its aberration leads to life-threatening diseases (Geoffroy and Hay, 2009) [1]. It was shown previously that the non-cov...

Descripción completa

Detalles Bibliográficos
Autores principales: Alontaga, Aileen Y., Ambaye, Nigus D., Li, Yi-Jia, Vega, Ramir, Chen, Chih-Hong, Bzymek, Krzysztof P., Williams, John C., Hu, Weidong, Chen, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927773/
https://www.ncbi.nlm.nih.gov/pubmed/27408909
http://dx.doi.org/10.1016/j.dib.2016.02.015
_version_ 1782440311167909888
author Alontaga, Aileen Y.
Ambaye, Nigus D.
Li, Yi-Jia
Vega, Ramir
Chen, Chih-Hong
Bzymek, Krzysztof P.
Williams, John C.
Hu, Weidong
Chen, Yuan
author_facet Alontaga, Aileen Y.
Ambaye, Nigus D.
Li, Yi-Jia
Vega, Ramir
Chen, Chih-Hong
Bzymek, Krzysztof P.
Williams, John C.
Hu, Weidong
Chen, Yuan
author_sort Alontaga, Aileen Y.
collection PubMed
description Post-translational modifications by the small ubiquitin-like modifiers (SUMO), in particular the formation of poly-SUMO-2 and -3 chains, regulates essential cellular functions and its aberration leads to life-threatening diseases (Geoffroy and Hay, 2009) [1]. It was shown previously that the non-covalent interaction between SUMO and the conjugating enzyme (E2) for SUMO, known as Ubc9, is required for poly-SUMO-2/3 chain formation (Knipscheer et al., 2007) [2]. However, the structure of SUMO-Ubc9 non-covalent complex, by itself, could not explain how the poly-SUMO-2/3 chain forms and consequently a Ubc9 homodimer, although never been observed, was proposed for poly-SUMO-2/3 chain formation (Knipscheer et al., 2007) [2]. Here, we solved the crystal structure of a heterotrimer containing a homodimer of Ubc9 and the RWD domain from RWDD3. The asymmetric Ubc9 homodimer is mediated by the N-terminal region of one Ubc9 molecule and a surface near the catalytic Cys of the second Ubc9 molecule (Fig. 1A). This N-terminal surface of Ubc9 that is involved in the homodimer formation also interacts with the RWD domain, the ubiquitin-fold domain of the SUMO activating enzyme (E1), SUMO, and the E3 ligase, RanBP2 (Knipscheer et al., 2007; Tong et al.. 1997; Tatham et al., 2005; Reverter and Lima, 2005; Capili and Lima, 2007; Wang et al., 2009, 2010; Wang and Chen, 2010; Alontaga et al., 2015) [2], [3], [4], [5], [6], [7], [8], [9], [10]. The existence of the Ubc9 homodimer in solution is supported by previously published solution NMR studies of rotational correlation time and chemical shift perturbation (Alontaga et al., 2015; Yuan et al., 1999) [10], [11]. Site-directed mutagenesis and biochemical analysis suggests that this dimeric arrangement of Ubc9 is likely important for poly-SUMO chain formation (Fig. 1B and C). The asymmetric Ubc9 homodimer described for the first time in this work could provide the critical missing link in the poly-SUMO chain formation mechanism. The data presented here are related to the research article entitled, “RWD domain as an E2 (Ubc9) interaction module” (Alontaga et al., 2015) [10]. The data of the crystal structure has been deposited to RCSB protein data bank with identifier: 4Y1L.
format Online
Article
Text
id pubmed-4927773
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-49277732016-07-12 Observation of an E2 (Ubc9)-homodimer by crystallography Alontaga, Aileen Y. Ambaye, Nigus D. Li, Yi-Jia Vega, Ramir Chen, Chih-Hong Bzymek, Krzysztof P. Williams, John C. Hu, Weidong Chen, Yuan Data Brief Data Article Post-translational modifications by the small ubiquitin-like modifiers (SUMO), in particular the formation of poly-SUMO-2 and -3 chains, regulates essential cellular functions and its aberration leads to life-threatening diseases (Geoffroy and Hay, 2009) [1]. It was shown previously that the non-covalent interaction between SUMO and the conjugating enzyme (E2) for SUMO, known as Ubc9, is required for poly-SUMO-2/3 chain formation (Knipscheer et al., 2007) [2]. However, the structure of SUMO-Ubc9 non-covalent complex, by itself, could not explain how the poly-SUMO-2/3 chain forms and consequently a Ubc9 homodimer, although never been observed, was proposed for poly-SUMO-2/3 chain formation (Knipscheer et al., 2007) [2]. Here, we solved the crystal structure of a heterotrimer containing a homodimer of Ubc9 and the RWD domain from RWDD3. The asymmetric Ubc9 homodimer is mediated by the N-terminal region of one Ubc9 molecule and a surface near the catalytic Cys of the second Ubc9 molecule (Fig. 1A). This N-terminal surface of Ubc9 that is involved in the homodimer formation also interacts with the RWD domain, the ubiquitin-fold domain of the SUMO activating enzyme (E1), SUMO, and the E3 ligase, RanBP2 (Knipscheer et al., 2007; Tong et al.. 1997; Tatham et al., 2005; Reverter and Lima, 2005; Capili and Lima, 2007; Wang et al., 2009, 2010; Wang and Chen, 2010; Alontaga et al., 2015) [2], [3], [4], [5], [6], [7], [8], [9], [10]. The existence of the Ubc9 homodimer in solution is supported by previously published solution NMR studies of rotational correlation time and chemical shift perturbation (Alontaga et al., 2015; Yuan et al., 1999) [10], [11]. Site-directed mutagenesis and biochemical analysis suggests that this dimeric arrangement of Ubc9 is likely important for poly-SUMO chain formation (Fig. 1B and C). The asymmetric Ubc9 homodimer described for the first time in this work could provide the critical missing link in the poly-SUMO chain formation mechanism. The data presented here are related to the research article entitled, “RWD domain as an E2 (Ubc9) interaction module” (Alontaga et al., 2015) [10]. The data of the crystal structure has been deposited to RCSB protein data bank with identifier: 4Y1L. Elsevier 2016-02-12 /pmc/articles/PMC4927773/ /pubmed/27408909 http://dx.doi.org/10.1016/j.dib.2016.02.015 Text en © 2016 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Data Article
Alontaga, Aileen Y.
Ambaye, Nigus D.
Li, Yi-Jia
Vega, Ramir
Chen, Chih-Hong
Bzymek, Krzysztof P.
Williams, John C.
Hu, Weidong
Chen, Yuan
Observation of an E2 (Ubc9)-homodimer by crystallography
title Observation of an E2 (Ubc9)-homodimer by crystallography
title_full Observation of an E2 (Ubc9)-homodimer by crystallography
title_fullStr Observation of an E2 (Ubc9)-homodimer by crystallography
title_full_unstemmed Observation of an E2 (Ubc9)-homodimer by crystallography
title_short Observation of an E2 (Ubc9)-homodimer by crystallography
title_sort observation of an e2 (ubc9)-homodimer by crystallography
topic Data Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927773/
https://www.ncbi.nlm.nih.gov/pubmed/27408909
http://dx.doi.org/10.1016/j.dib.2016.02.015
work_keys_str_mv AT alontagaaileeny observationofane2ubc9homodimerbycrystallography
AT ambayenigusd observationofane2ubc9homodimerbycrystallography
AT liyijia observationofane2ubc9homodimerbycrystallography
AT vegaramir observationofane2ubc9homodimerbycrystallography
AT chenchihhong observationofane2ubc9homodimerbycrystallography
AT bzymekkrzysztofp observationofane2ubc9homodimerbycrystallography
AT williamsjohnc observationofane2ubc9homodimerbycrystallography
AT huweidong observationofane2ubc9homodimerbycrystallography
AT chenyuan observationofane2ubc9homodimerbycrystallography